Syndax Pharmaceuticals, Inc. - Common Stock (NQ:SNDX)
Price and Volume
Detailed Quote| Volume | 1,010,908 |
| Open | 19.58 |
| Bid (Size) | 19.32 (200) |
| Ask (Size) | 19.92 (100) |
| Prev. Close | 19.61 |
| Today's Range | 19.31 - 19.80 |
| 52wk Range | 8.585 - 25.59 |
| Shares Outstanding | 69,484,053 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Syndax (SNDX) Q4 2025 Earnings Call Transcript ↗
February 27, 2026
Syndax Announces Participation in March Investor Conferences
February 23, 2026
Frequently Asked Questions
Is Syndax Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Syndax Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Syndax Pharmaceuticals, Inc. - Common Stock trade on?
Syndax Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Syndax Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Syndax Pharmaceuticals, Inc. - Common Stock is SNDX on the Nasdaq Stock Market
What is the current price of Syndax Pharmaceuticals, Inc. - Common Stock?
The current price of Syndax Pharmaceuticals, Inc. - Common Stock is 19.75
When was Syndax Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Syndax Pharmaceuticals, Inc. - Common Stock was at 05/28/26 04:00 PM ET
What is the market capitalization of Syndax Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Syndax Pharmaceuticals, Inc. - Common Stock is 1.37B
How many shares of Syndax Pharmaceuticals, Inc. - Common Stock are outstanding?
Syndax Pharmaceuticals, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Copyright 2024. BUSINESS INSURANCE HOLDINGS
